Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-01-24 @ 8:11 AM
Study NCT ID:
NCT01573468
Status:
UNKNOWN
Last Update Posted:
2012-07-24
First Post:
2012-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer
Sponsor:
Genta Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Carcinoma | View |
Keywords: